Omeros Corporation today announced that the first commercial shipments of YARTEMLEA® (narsoplimab-wuug) to its distributors were completed last week, with orders from transplant centers beginning that ...

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a growing societal burden exacerbated by population aging. Traditional ...

Investing.com -- Omeros Corporation (NASDAQ:OMER) stock rose 3.1% on Tuesday after the company announced it has completed its ...

Hydrogels are among the most widely studied biomaterials in modern drug delivery research. Their high hydrophilicity, ...